August 13, 2021
1 min read

Decision on Covaxin emergency authorisation expected by Sept: MEA

The World Health Organisation has said the agency expects to make a decision next month on an emergency authorisation for the Indian-made COVID-19 vaccine….reports Asian Lite News

The Ministry of External Affairs (MEA) on Thursday said a decision on emergency authorisation for the Covaxin Covid-19 vaccine made by Bharat Biotech is expected to be announced by September as the World Health Organisation (WHO) takes 6-8 weeks to grant the emergency use listing.

In a media briefing, MEA spokesperson Arindam Bagchi said, “Covaxin submitted its application on July 9 so we are expecting a response by September as it takes 6-8 weeks for the WHO to grant the EUL.”

External Affairs Minister S Jaishankar had made a similar statement at the CII annual event.

The World Health Organisation has said the agency expects to make a decision next month on an emergency authorisation for the Indian-made COVID-19 vaccine.

Last week, Bharat Biotech’s Covaxin received a Good Manufacturing Practices (GMP) compliance certificate from Hungary. The certificate of GMP is now listed on the EudraGMDP database which is the collection of records of the European Community of manufacturing authorisations and certificates of good manufacturing practice, Bharat Biotech said.

Asked about the actions taken by the government on easing Covid travel restrictions, the MEA Spokesperson said, “There are many countries where Covid restrictions are there. Not just students, other people who would like to travel are facing problems. As I have said earlier, we attach high importance to ensuring ease of these restrictions whether they live abroad for education or employment. We have been actively taking up this matter at various levels including at the ministerial levels with all of the countries. I am happy to see some forward movements with some of the countries. MEA will continue to attach high priority to this issue.” (India News Network)

ALSO READ: No compromise on Covaxin quality, says Bharat Biotech

ALSO READ: Nod for proposal to study mixing of Covid-19 vaccine doses

Previous Story

Mayor, film industry urge Londoners ‘Back to the Big Screen’

Next Story

Right to shelter doesn’t mean govt housing for unlimited period: SC

Latest from -Top News

US Sticks to August 1 Tariff Deadline

US Commerce Secretary Howard Lutnick ruled out any possibility of an extension…reports Asian Lite News The US administration on Sunday said the August 1 deadline for imposing reciprocal tariffs remains unchanged and

EU Lawmaker Slams US Trade Deal

US President Donald Trump and European Commission President Ursula von der Leyen announced earlier in the day that they had reached a trade agreement…reports Asian Lite News A top EU lawmaker has

Killing Fields of Gaza

While Israeli airstrikes on Gaza continue to dominate global headlines after hundreds of days of conflict, a parallel and equally devastating crisis is unfolding — one that receives far less attention: deepening

EU, China United on Climate, Split on Rest

Climate pact offers rare unity as trade rifts, Ukraine war, and economic tensions dominate EU-China summitChina and the European Union struck a rare note of unity on climate change Thursday, issuing a

Hungary Pays the Trump Price

Despite his success in wooing Trump’s conservative base, Hungary is among the EU nations most vulnerable to Trump’s incoming tariff blitz Hungary’s populist Prime Minister Viktor Orbán has spent years forging close
Go toTop

Don't Miss

Indian-American physician seeks GOP nomination in Kansas district

In his campaign statement, launched Wednesday, Reddy called for secure

Putin praises India’s global role in Independence Day message

Putin wished the best of health and every success as